| __timestamp | United Therapeutics Corporation | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 242549000 | 18516000 |
| Thursday, January 1, 2015 | 245098000 | 34140000 |
| Friday, January 1, 2016 | 147600000 | 51872000 |
| Sunday, January 1, 2017 | 264600000 | 71772000 |
| Monday, January 1, 2018 | 357900000 | 97501000 |
| Tuesday, January 1, 2019 | 1182600000 | 118590000 |
| Wednesday, January 1, 2020 | 357700000 | 169802000 |
| Friday, January 1, 2021 | 540100000 | 192507000 |
| Saturday, January 1, 2022 | 322900000 | 199563000 |
| Sunday, January 1, 2023 | 408000000 | 253598000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Xencor, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, United Therapeutics Corporation has consistently outpaced Xencor, Inc. in R&D spending, with a peak in 2019 where their investment was nearly five times that of Xencor. However, Xencor has shown a steady increase, with their R&D expenses growing by over 1,200% from 2014 to 2023. This trend highlights Xencor's aggressive push towards innovation, despite being a smaller player.
As the biotech landscape evolves, these spending patterns offer a glimpse into the strategic priorities of these companies, with United Therapeutics focusing on maintaining its lead, while Xencor aims to close the gap.
AstraZeneca PLC or Xencor, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Xencor, Inc.
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
United Therapeutics Corporation vs Xencor, Inc.: SG&A Expense Trends
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.
R&D Insights: How PTC Therapeutics, Inc. and Xencor, Inc. Allocate Funds
Analyzing R&D Budgets: Travere Therapeutics, Inc. vs Xencor, Inc.